Evidence map›Paper›PMID 36312923›Full record

ArticleFrontiers in microbiology2022

Mirror proteases of Ac-Trypsin and Ac-LysargiNase precisely improve novel event identifications in

Songhao Jiang, Jiahui Shi, Yanchang Li, Zhenpeng Zhang, Lei Chang, Guibin Wang, Wenhui Wu, Liyan Yu, Erhei Dai, Lixia Zhang and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Songhao JiangKey Laboratory of Microbial Diversity Research and Application of Hebei, School of Life Sciences, Hebei University, Baoding, China.
Jiahui ShiBeijing Proteome Research Center, National Center for Protein Sciences Beijing, State Key Laboratory of Proteomics, Research Unit of Proteomics and Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing, China.
Yanchang LiBeijing Proteome Research Center, National Center for Protein Sciences Beijing, State Key Laboratory of Proteomics, Research Unit of Proteomics and Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing, China.
Zhenpeng ZhangBeijing Proteome Research Center, National Center for Protein Sciences Beijing, State Key Laboratory of Proteomics, Research Unit of Proteomics and Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing, China.
Lei ChangBeijing Proteome Research Center, National Center for Protein Sciences Beijing, State Key Laboratory of Proteomics, Research Unit of Proteomics and Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing, China.
Guibin WangBeijing Proteome Research Center, National Center for Protein Sciences Beijing, State Key Laboratory of Proteomics, Research Unit of Proteomics and Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing, China.
Wenhui WuBeijing Proteome Research Center, National Center for Protein Sciences Beijing, State Key Laboratory of Proteomics, Research Unit of Proteomics and Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing, China.
Liyan YuResearch Unit of Proteomics and Research and Development of New Drug, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Erhei DaiThe Fifth Hospital of Shijiazhuang, School of Public Health, Shijiazhuang, China.
Lixia ZhangKey Research Laboratory for Infectious Disease Prevention for State Administration of Traditional Chinese Medicine, Tianjin Institute of Respiratory Diseases, Haihe Hospital, Tianjin University, Tianjin, China.
Zhitang LyuKey Laboratory of Microbial Diversity Research and Application of Hebei, School of Life Sciences, Hebei University, Baoding, China.
Ping XuKey Laboratory of Microbial Diversity Research and Application of Hebei, School of Life Sciences, Hebei University, Baoding, China.
Yao ZhangBeijing Proteome Research Center, National Center for Protein Sciences Beijing, State Key Laboratory of Proteomics, Research Unit of Proteomics and Research and Development of New Drug of Chinese Academy of Medical Sciences, Institute of Lifeomics, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate identification of novel peptides remains challenging because of the lack of evaluation criteria in large-scale proteogenomic studies. Mirror proteases of trypsin and lysargiNase can generate complementary

Indexed as

Ac-LysargiNaseAc-TrypsinmirrorMycolicibacterium smegmatisproteogenomics

Identifiers

PMID36312923
PMCPMC9597629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.